Enliven Therapeutics
ELVN
#5218
Rank
S$1.57 B
Marketcap
$33.27
Share price
5.84%
Change (1 day)
78.01%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2024 : S$0.22 M

According to Enliven Therapeutics's latest financial reports the company's total debt is S$0.22 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$0.44 M2.18%
2022-12-31S$0.43 M101.94%
2021-12-31S$0.21 M54.47%
2020-12-31S$0.13 M